Changes To Part D Protected Classes Uniformly Opposed At House Hearing
This article was originally published in The Pink Sheet Daily
Executive Summary
In a hearing on CMS’ proposed Medicare Part D rule, members of the Energy & Commerce Health Subcommittee agreed that the potential cost savings to Medicare through its plan to remove antidepressants, antipsychotics and immunosuppressants from Part D “protected class” status do not outweigh the downside for beneficiaries.